Singapore markets close in 57 minutes

Straits Times Index
3,300.70
+3.81(+0.12%)
Nikkei
38,236.07
-37.98(-0.10%)
Hang Seng
18,451.38
+244.25(+1.34%)
FTSE 100
8,197.37
+25.22(+0.31%)
Bitcoin USD
59,186.64
+1,451.19(+2.51%)
CMC Crypto 200
1,291.54
+14.56(+1.14%)

VIR May 2024 15.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.2000

0.0000

(0.00%)

As of 09:30AM EDT. Market open.

Zacks
Vir Biotechnology, Inc. (VIR) Reports Q1 Loss, Tops Revenue Estimates
Vir Biotechnology (VIR) delivered earnings and revenue surprises of 51.52% and 250.82%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Business Wire
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
SAN FRANCISCO, May 02, 2024--Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the first quarter ended March 31, 2024.
Business Wire
Vir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024
SAN FRANCISCO, April 30, 2024--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer is scheduled to participate in a fireside chat at the BofA Securities Healthcare Conference 2024 on Tuesday, May 14, at 4:20 p.m. PT / 7:20 p.m. ET.